MBP8298

· BioMS Technology Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBP8298, covering 2009-08-13 to 2009-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis [Phase 3]